Genfit S.A (GNFT) | Financial Analysis & Statements
Genfit S.A. | Mid-cap | Healthcare
Genfit S.A. | Mid-cap | Healthcare
Financial Overview
Latest Annual: 2024Income Metrics
Revenue
67.0M
Gross Profit
66.7M
99.55%
Operating Income
3.2M
4.81%
Net Income
1.5M
2.25%
Balance Sheet Metrics
Total Assets
151.4M
Total Liabilities
82.2M
Shareholders Equity
69.2M
Debt to Equity
1.19
Cash Flow Metrics
Operating Cash Flow
15.5M
Free Cash Flow
14.6M
Revenue & Profitability Trend
Genfit S.A Income Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 67.0M | 28.6M | 20.2M | 80.1M | 765.0K |
| Cost of Goods Sold | 300.0K | 341.0K | 251.0K | 162.0K | 202.0K |
| Gross Profit | 66.7M | 28.2M | 19.9M | 79.9M | 563.0K |
| Operating Expenses | 63.1M | 55.1M | 47.1M | 47.0M | 77.6M |
| Operating Income | 3.2M | -27.2M | -27.3M | 32.4M | -77.5M |
| Pre-tax Income | 1.8M | -28.5M | -23.8M | 69.5M | -101.6M |
| Income Tax | 340.0K | 380.0K | -116.0K | 2.2M | -428.0K |
| Net Income | 1.5M | -28.9M | -23.7M | 67.3M | -101.2M |
| EPS (Diluted) | - | -€0.58 | -€0.48 | €1.23 | -€2.60 |
Income Statement Trend
Genfit S.A Balance Sheet From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | 92.8M | 113.1M | 158.5M | 268.1M | 184.7M |
| Non-Current Assets | 58.7M | 60.8M | 57.1M | 13.6M | 13.4M |
| Total Assets | 151.4M | 173.9M | 215.5M | 281.7M | 198.1M |
| Liabilities | |||||
| Current Liabilities | 75.2M | 38.5M | 39.4M | 62.8M | 31.1M |
| Non-Current Liabilities | 7.0M | 67.4M | 81.6M | 99.8M | 183.5M |
| Total Liabilities | 82.2M | 105.9M | 121.0M | 162.6M | 214.5M |
| Equity | |||||
| Total Shareholders Equity | 69.2M | 68.0M | 94.5M | 119.1M | -16.4M |
Balance Sheet Composition
Genfit S.A Cash Flow Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 1.5M | -28.9M | -23.7M | 67.3M | -101.2M |
| Operating Cash Flow | 15.5M | -54.5M | -72.3M | 101.5M | -99.5M |
| Investing Activities | |||||
| Capital Expenditures | -899.0K | -242.0K | 271.0K | -102.0K | -900.0K |
| Investing Cash Flow | -1.0M | 4.3M | -46.3M | -3.3M | -966.0K |
| Financing Activities | |||||
| Dividends Paid | - | - | 0 | 0 | 0 |
| Financing Cash Flow | -10.6M | -5.1M | -3.8M | -8.9M | -494.0K |
| Free Cash Flow | 14.6M | -57.9M | -72.6M | 99.4M | -97.3M |
Cash Flow Trend
Genfit S.A Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
111.73
Forward P/E
17.79
Price to Book
2.41
Price to Sales
2.37
Profitability Ratios
Profit Margin
2.13%
Operating Margin
-293.86%
Return on Equity
2.20%
Return on Assets
1.15%
Financial Health
Current Ratio
1.23
Debt to Equity
89.76
Beta
1.29
Per Share Data
EPS (TTM)
€0.03
Book Value per Share
€1.39
Revenue per Share
€1.42
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| gnft | 167.6M | 111.73 | 2.41 | 2.20% | 2.13% | 89.76 |
| Medincell S.A | 565.5M | -18.81 | - | 61.33% | -66.50% | -1.44 |
| Valneva SE | 409.5M | 70.64 | 2.11 | -44.11% | -43.21% | 120.48 |
| BNP Paribas Easy | 456.7M | 15.91 | - | -96.39% | -27.22% | 2.22 |
| Abivax SA | 331.7M | -1.96 | -52.78 | -196.12% | 0.00% | -16.16 |
| Inventiva S.A | 379.0M | -0.88 | -0.99 | 172.73% | 0.00% | -1.70 |
Financial data is updated regularly. All figures are in the company's reporting currency.